Carfilzomib And Pomalidomide Pass Phase II

Proteolix’s novel proteasome inhibitor set for larger trial of relapsed, refractory myeloma.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet